{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:37:33Z","timestamp":1788521853489,"version":"build-2803163510"},"reference-count":122,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["transplantationreviews.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.trre.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T06:00:18Z","timestamp":1502776818000},"page":"257-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Defining the phenotype of antibody-mediated rejection in kidney transplantation: Advances in diagnosis of antibody injury"],"prefix":"10.1016","volume":"31","author":[{"given":"Neetika","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros D.","family":"Samaniego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjang","family":"Djamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2017.08.005_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.14124","article-title":"OPTN\/SRTR 2015 Annual Data Report: Kidney","volume":"17","author":"Hart","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/TP.0b013e3181e065de","article-title":"Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure","volume":"90","author":"Gaston","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0015","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"Einecke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrneph.2012.61","article-title":"Diagnostic challenges in chronic antibody-mediated rejection","volume":"8","author":"Farkash","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ki.1993.259","article-title":"International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology","volume":"44","author":"Solez","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2017.08.005_bb0035","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria \u2014 an addition to the Banff 97 classification of renal allograft rejection","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0040","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff '05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (\u2018CAN\u2019)","volume":"7","author":"Solez","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0045","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/01.tp.0000287457.54761.53","article-title":"The involvement of FcR mechanisms in antibody-mediated rejection","volume":"84","author":"Lee","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0050","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0055","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/j.1600-6143.2009.02761.x","article-title":"Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining","volume":"9","author":"Sis","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ajt.14107","article-title":"The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology","volume":"17","author":"Loupy","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-6143.2010.03364.x","article-title":"Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)","volume":"11","author":"Loupy","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0070","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.1600-6143.2009.02813.x","article-title":"Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies","volume":"9","author":"Loupy","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0075","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/TP.0b013e318277b2e2","article-title":"The clinical and molecular significance of C4d staining patterns in renal allografts","volume":"95","author":"Hayde","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1600-6143.2011.03926.x","article-title":"Banff 2011 meeting report: new concepts in antibody-mediated rejection","volume":"12","author":"Mengel","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0085","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0090","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.transproceed.2012.11.025","article-title":"Long-term follow-up of non-HLA and anti-HLA antibodies: incidence and importance in renal transplantation","volume":"45","author":"Banasik","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2017.08.005_bb0095","series-title":"American Journal of Transplantation","article-title":"HLA donor-specific antibody (DSA) negative antibody-mediated rejection (AMR): incidence, treatment and outcomes. [abstract]","author":"Redfield","year":"2017"},{"key":"10.1016\/j.trre.2017.08.005_bb0100","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1681\/ASN.2013121277","article-title":"Endothelial cell antibodies associated with novel targets and increased rejection","volume":"26","author":"Jackson","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0105","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss","volume":"13","author":"Giral","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0110","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1600-6143.2011.03931.x","article-title":"A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants","volume":"12","author":"Sis","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/TP.0000000000000310","article-title":"Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy","volume":"99","author":"Lesage","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0120","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0125","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2016.10.040","article-title":"Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent\/recurrent versus de novo donor-specific antibodies","author":"Haas","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2017.08.005_bb0135","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.12478","article-title":"Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0140","doi-asserted-by":"crossref","first-page":"e3094","DOI":"10.1097\/MD.0000000000003094","article-title":"Clinical significance of HLA-DQ antibodies in the development of chronic antibody-mediated rejection and allograft failure in kidney transplant recipients","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.trre.2017.08.005_bb0145","doi-asserted-by":"crossref","DOI":"10.1097\/01.tp.0000437177.40551.f4","article-title":"Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients","author":"Bagnasco","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0150","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1600-6143.2006.01657.x","article-title":"Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts","volume":"7","author":"Haas","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0155","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1097\/TP.0000000000001012","article-title":"De novo anti-HLA DSA characteristics and subclinical antibody-mediated kidney allograft injury","volume":"100","author":"Yamamoto","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0160","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2014040399","article-title":"Subclinical rejection phenotypes at 1year post-transplant and outcome of kidney allografts","volume":"26","author":"Loupy","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0165","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/ajt.12982","article-title":"Quantifying renal allograft loss following early antibody-mediated rejection","volume":"15","author":"Orandi","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0170","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(05)66458-6","article-title":"Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies","volume":"365","author":"Opelz","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2017.08.005_bb0175","first-page":"449","article-title":"Deduction of the fraction of immunologic and non-immunologic failure in cadaver donor transplants","author":"Terasaki","year":"2003","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2017.08.005_bb0180","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1600-6143.2004.00463.x","article-title":"Systemic up-regulation of angiotensin II type 1 receptor in cardiac donors with spontaneous intracerebral hemorrhage","volume":"4","author":"Yamani","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0185","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2017.08.005_bb0190","article-title":"The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation","author":"Lee","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0195","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","article-title":"Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies","volume":"13","author":"Taniguchi","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0200","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.humimm.2012.07.010","article-title":"Non-HLA-antibodies targeting Angiotensin type 1 receptor and antibody mediated rejection","volume":"73","author":"Dragun","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trre.2017.08.005_bb0205","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.kint.2016.03.019","article-title":"Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity","volume":"90","author":"Dragun","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2017.08.005_bb0210","article-title":"Anti-angiotensin II type 1 receptor and anti-endothelial cell antibodies: a cross-sectional analysis of pathological findings in allograft biopsies","author":"Philogene","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0215","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMc1207233","article-title":"Angiotensin antibodies and focal segmental glomerulosclerosis","volume":"368","author":"Alachkar","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2017.08.005_bb0220","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/ctr.12562","article-title":"Pre-transplant angiotensin receptor II type 1 antibodies and risk of post-transplant focal segmental glomerulosclerosis recurrence","volume":"29","author":"Mujtaba","year":"2015","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2017.08.005_bb0225","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00467-011-1864-3","article-title":"Acute antibody-mediated rejection in paediatric renal transplant recipients","volume":"26","author":"Kranz","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0230","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/TP.0b013e318234b337","article-title":"Accelerated kidney transplant rejection and hypertensive encephalopathy in a pediatric patient associated with antibodies against angiotensin type 1 receptor and HLA class II","volume":"92","author":"Kelsch","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0235","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/j.transproceed.2014.09.029","article-title":"Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss","volume":"46","author":"Banasik","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2017.08.005_bb0240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.trim.2013.10.007","article-title":"The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes","volume":"30","author":"Banasik","year":"2014","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trre.2017.08.005_bb0245","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trre.2017.08.005_bb0250","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1096\/fj.03-0573fje","article-title":"Apoptosis of endothelial cells triggers a caspase-dependent anti-apoptotic paracrine loop active on VSMC","volume":"18","author":"Raymond","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.trre.2017.08.005_bb0255","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.4049\/jimmunol.174.9.5740","article-title":"Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis","volume":"174","author":"Laplante","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2017.08.005_bb0260","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/ajt.12168","article-title":"Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury","volume":"13","author":"Cardinal","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0265","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1161\/CIRCRESAHA.111.250431","article-title":"The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection","volume":"110","author":"Soulez","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.trre.2017.08.005_bb0270","article-title":"The emerging importance of non-HLA autoantibodies in kidney transplant complications","author":"Cardinal","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0275","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.13866","article-title":"Anti-LG3 antibodies aggravate renal ischemia-reperfusion injury and long-term renal allograft dysfunction","author":"Yang","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0280","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/ajt.12763","article-title":"Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss","volume":"14","author":"Gao","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0285","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-6143.2005.00690.x","article-title":"Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy","volume":"5","author":"Joosten","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0290","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/ajt.12592","article-title":"Immune responses to collagen-IV and fibronectin in renal transplant recipients with transplant glomerulopathy","volume":"14","author":"Angaswamy","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0295","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.humimm.2013.06.014","article-title":"Vimentin antibody production in transplant patients and immunomodulatory effects of vimentin in-vitro","volume":"74","author":"Carter","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trre.2017.08.005_bb0300","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.transproceed.2004.12.043","article-title":"Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation","volume":"37","author":"Carter","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2017.08.005_bb0305","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.transproceed.2005.09.062","article-title":"Anti-vimentin antibody detection in recipients of heart-beating and non-heart beating donor kidneys","volume":"37","author":"Mi","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2017.08.005_bb0315","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.humimm.2006.02.007","article-title":"Frequency of MIC antibody in rejected renal transplant patients without HLA antibody","volume":"67","author":"Mizutani","year":"2006","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trre.2017.08.005_bb0320","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1600-6143.2006.01721.x","article-title":"The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients","volume":"7","author":"Mizutani","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0325","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.transproceed.2007.02.009","article-title":"Monitoring of anti-HLA and anti-major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation","volume":"39","author":"Panigrahi","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2017.08.005_bb0330","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa067160","article-title":"Antibodies against MICA antigens and kidney-transplant rejection","volume":"357","author":"Zou","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2017.08.005_bb0335","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1399-0039.2010.01527.x","article-title":"Role of MICA in the immune response to transplants","volume":"76","author":"Zou","year":"2010","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.trre.2017.08.005_bb0340","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.humimm.2016.05.021","article-title":"Pathogenesis of non-HLA antibodies in solid organ transplantation: where do we stand?","volume":"77","author":"Delville","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trre.2017.08.005_bb0345","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/TP.0b013e3181949d4e","article-title":"Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation","volume":"87","author":"Breimer","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0350","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/TP.0b013e31821b60e9","article-title":"Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood","volume":"92","author":"Jackson","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0355","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.humimm.2011.07.001","article-title":"Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads","volume":"72","author":"Chen","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trre.2017.08.005_bb0360","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.healun.2010.08.020","article-title":"Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients","volume":"30","author":"Chin","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0365","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1399-3046.2011.01599.x","article-title":"Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss","volume":"16","author":"Sutherland","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0370","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e318203fd26","article-title":"C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation","volume":"91","author":"Yabu","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0375","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2014111120","article-title":"IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury","volume":"27","author":"Lefaucheur","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0380","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2017.08.005_bb0385","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/TP.0b013e3182743cfa","article-title":"Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts","volume":"95","author":"Lawrence","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0390","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/TP.0000000000000699","article-title":"C1q binding activity of de novo donor-specific HLA antibodies in renal transplant recipients with and without antibody-mediated rejection","volume":"99","author":"Yell","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0395","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2014040326","article-title":"Non-complement-binding de novo donor-specific anti-HLA antibodies and kidney allograft survival","volume":"27","author":"Guidicelli","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0400","article-title":"C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study","author":"Moktefi","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2017.08.005_bb0405","article-title":"Evaluation of C1q status and titer of de novo donor-specific antibodies as predictors of allograft survival","author":"Wiebe","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0410","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss","volume":"26","author":"Sicard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0415","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/ajt.13700","article-title":"Acquisition of C3d-binding activity by de novo donor-specific HLA antibodies correlates with graft loss in nonsensitized pediatric kidney recipients","volume":"16","author":"Comoli","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2017.02.003","article-title":"Relationship between mean fluorescence intensity and C1q\/C3d-fixing capacities of anti-hla antibodies","author":"Claisse","year":"2017","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trre.2017.08.005_bb0425","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780198729426.003.0030","article-title":"Eculizumab therapy for chronic antibody-mediated injury in kidney transplant recipients: a pilot randomized controlled trial","author":"Kulkarni","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0430","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.TP.0000062835.30165.2C","article-title":"Complement activation in early protocol kidney graft biopsies after living-donor transplantation","volume":"75","author":"Sund","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0435","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.TP.0000069040.16457.06","article-title":"C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome","volume":"76","author":"Kuypers","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0440","doi-asserted-by":"crossref","first-page":"397613","DOI":"10.1155\/2015\/397613","article-title":"Capillary deposition of complement C4d and C3d in Chinese renal allograft biopsies","volume":"2015","author":"Lv","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.trre.2017.08.005_bb0445","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1034\/j.1600-6143.2003.00179.x","article-title":"Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury","volume":"3","author":"Park","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0450","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1097\/01.ASN.0000030140.74450.0B","article-title":"C4d and the fate of organ allografts","volume":"13","author":"Platt","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0455","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1172\/JCI41789","article-title":"A molecular classifier for predicting future graft loss in late kidney transplant biopsies","volume":"120","author":"Einecke","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trre.2017.08.005_bb0460","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","article-title":"NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection","volume":"10","author":"Hidalgo","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0465","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/ajt.12150","article-title":"Molecular diagnosis of antibody-mediated rejection in human kidney transplants","volume":"13","author":"Sellares","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0470","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/ajt.12465","article-title":"Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM)","volume":"13","author":"Halloran","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0475","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MOT.0000000000000193","article-title":"The molecular phenotypes of rejection in kidney transplant biopsies","volume":"20","author":"Halloran","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0480","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nrneph.2016.85","article-title":"Molecular assessment of disease states in kidney transplant biopsy samples","volume":"12","author":"Halloran","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0485","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/ajt.13551","article-title":"Identifying subphenotypes of antibody-mediated rejection in kidney transplants","volume":"16","author":"Halloran","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0490","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/ajt.13934","article-title":"A probabilistic approach to histologic diagnosis of antibody-mediated rejection in kidney transplant biopsies","volume":"17","author":"Halloran","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0495","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.14200","article-title":"Comprehensive analysis of transcript changes associated with allograft rejection: combining universal and selective features","author":"Halloran","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0500","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1681\/ASN.2013111149","article-title":"Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection","volume":"25","author":"Loupy","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0505","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ki.2015.276","article-title":"Clinical and molecular significance of microvascular inflammation in transplant kidney biopsies","volume":"89","author":"Gupta","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2017.08.005_bb0510","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ki.2014.75","article-title":"Increased intragraft rejection-associated gene transcripts in patients with donor-specific antibodies and normal biopsies","volume":"86","author":"Hayde","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2017.08.005_bb0515","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2016080858","article-title":"Moving biomarkers toward clinical implementation in kidney transplantation","author":"Menon","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0520","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1111\/j.1523-1755.2004.00663.x","article-title":"Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine","volume":"65","author":"Tatapudi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2017.08.005_bb0525","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa051907","article-title":"Messenger RNA for FOXP3 in the urine of renal-allograft recipients","volume":"353","author":"Muthukumar","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2017.08.005_bb0530","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1600-6143.2009.02645.x","article-title":"Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis","volume":"9","author":"Schaub","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0535","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/TP.0b013e3181ffbadd","article-title":"Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts","volume":"90","author":"Afaneh","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0540","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/ajt.12284","article-title":"Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling","volume":"13","author":"Keslar","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0545","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1215555","article-title":"Urinary-cell mRNA profile and acute cellular rejection in kidney allografts","volume":"369","author":"Suthanthiran","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2017.08.005_bb0550","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1681\/ASN.2013080900","article-title":"Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction","volume":"25","author":"Matignon","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0555","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/TP.0000000000000419","article-title":"Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation","volume":"99","author":"Blydt-Hansen","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2017.08.005_bb0560","doi-asserted-by":"crossref","first-page":"e64994","DOI":"10.1371\/journal.pone.0064994","article-title":"Renal and urinary levels of endothelial protein C receptor correlate with acute renal allograft rejection","volume":"8","author":"Lattenist","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2017.08.005_bb0565","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1681\/ASN.2014080797","article-title":"Urinary C-X-C motif chemokine 10 independently improves the noninvasive diagnosis of antibody-mediated kidney allograft rejection","volume":"26","author":"Rabant","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0570","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1111\/j.1600-6143.2012.04253.x","article-title":"A peripheral blood diagnostic test for acute rejection in renal transplantation","volume":"12","author":"Li","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0575","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1600-6143.2004.00526.x","article-title":"Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes","volume":"4","author":"Flechner","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0580","doi-asserted-by":"crossref","first-page":"e1001759","DOI":"10.1371\/journal.pmed.1001759","article-title":"The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study","volume":"11","author":"Roedder","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.trre.2017.08.005_bb0585","doi-asserted-by":"crossref","first-page":"e60702","DOI":"10.1371\/journal.pone.0060702","article-title":"Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection","volume":"8","author":"Danger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2017.08.005_bb0590","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/j.1600-6143.2012.04003.x","article-title":"Comparison of C4d detection on erythrocytes and PTC-C4d to histological signs of antibody-mediated rejection in kidney transplantation","volume":"12","author":"Haidar","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0595","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.transproceed.2015.08.035","article-title":"Donor-derived cell-free DNA is a novel universal biomarker for allograft rejection in solid organ transplantation","volume":"47","author":"Beck","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2017.08.005_bb0600","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1373\/clinchem.2008.113597","article-title":"Profile of the circulating DNA in apparently healthy individuals","volume":"55","author":"Beck","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.trre.2017.08.005_bb0605","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1111\/ajt.13387","article-title":"Cell-free DNA: an upcoming biomarker in transplantation","volume":"15","author":"Gielis","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2017.08.005_bb0610","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2016091034","article-title":"Circulating donor-derived cell-free, cell-free dna and active rejection in kidney allografts","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2017.08.005_bb0615","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000001662","article-title":"Urinary metabolomics for noninvasive detection of antibody-mediated rejection in children after kidney transplantation","author":"Blydt-Hansen","year":"2017","journal-title":"Transplantation"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X1730040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X1730040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T12:05:59Z","timestamp":1570017959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X1730040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0955470X1730040X"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2017.08.005","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining the phenotype of antibody-mediated rejection in kidney transplantation: Advances in diagnosis of antibody injury","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}